Keyphrases
Acetonitrile
66%
Adult Patients
33%
AZD9291
100%
Between-day
33%
Blood Plasma
33%
C18 Column
33%
Covalent Inhibitor
33%
EGFR Inhibitors
100%
EGFR-TK
33%
Electrospray Interface
33%
Formic Acid
33%
Gradient Elution
33%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
33%
Highly Selective
33%
Human Plasma
100%
Limit of Quantification
33%
Liquid Chromatography-tandem Mass
100%
Liquid-liquid Extraction
33%
Lithium Heparin
33%
Lung Carcinoma
33%
Magnesium Sulfate
33%
Mass Spectrometry
100%
Mobile Phase
33%
Monitoring Mode
33%
Mutant EGFR
100%
Non-small
33%
Osimertinib
100%
Pazopanib
33%
Plasma Parameters
33%
Salting-out
33%
Selected Reaction Monitoring
33%
Sodium
33%
Spectrometric Assay
100%
T790M
100%
Therapeutic Drug Monitoring
33%
Tri-functional
33%
Triple Quadrupole Mass Spectrometer
33%
Within-day
33%
Chemistry
Acetonitrile
66%
Electrosprays
33%
Ethylenediaminetetraacetic Acid
33%
Formic Acid
33%
Gradient Elution
33%
Heparin
33%
Liquid Chromatography
100%
Lithium
33%
Magnesium Sulfate
33%
Mobile Phase Composition
33%
Osimertinib
100%
Pazopanib
33%
Plasma Level
33%
Quadrupole
33%
Salting Out
33%
Sodium
33%
Solvent Extraction
33%
Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acetonitrile
50%
Electrospray Ionization
25%
Epidermal Growth Factor Receptor
100%
Ethylenediaminetetraacetic Acid
25%
Formate
25%
Heparin
25%
Lung Carcinoma
25%
Magnesium Sulfate
25%
Osimertinib
100%
Pazopanib
25%
Therapeutic Drug Monitoring
25%
Ultra High Performance Liquid Chromatography
25%